Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019209 (
hepatomegaly
)
5,798
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
One hundred patients on chronic haemodialysis were studied prospectively over one year for evidence of hepatitis and of infection with
hepatitis A
or B virus. Five patients developed transient elevations of SGPT, accompanied by a consistent pattern of clinical manifestations, including low-grade fever, anorexia, nausea,
hepatomegaly
, and hypotension during dialysis. None of these patients had a positive test for A or B virus infection. Non-A non-B hepatitis appears to cause a specific syndrome in uraemic patients, and its transmission in a dialysis unit seems unrelated to blood transfusions.
...
PMID:Non-A, non-B hepatitis: a new syndrome in uraemic patients. 12 59
In a 12-year-old female patients with HBAg phi
hepatitis a
differential diagnosis of the diseases has been considered. The CMV etiology of the hepatitis was suspected on the basis of a persistent temperature,
hepatomegaly
, a mild icterus, enlarged glands in the neck, predominantly mononuclear cells in the peripheral blood, a negative Paul-Bunnell test, and insufficiently characteristic biochemical analyses for virus A hepatitis. The CMV etiology of the disease was virologically confirmed. On the basis of the clinical picture without virological results, the diagnosis could not have been made with certainty.
...
PMID:Cytomegalovirus hepatitis (diagnosis and differential diagnosis). 20 Nov 33
The nonerythropoietic component of early labeled bilirubin in plasma and bile was studied in 7 patients with acute
infectious hepatitis
during the late convalescent stage, in 13 patients with Laennec-type liver cirrhosis, and in 7 control subjects after intravenous injection of a tracer dose (2.5 muCi) of 4-14C-delta-aminolevulinic acid (14C-deltaALA). All subjects were examined during the nonicteric stage. In control subjects, the mean cumulative radioactivity readings in 4 hours were 29.6 +/- 4.7 X 10(3) d.p.m. per milligram times 4 hours in plasma and 27.0 +/- 1.2 X 10(3) d.p.m. per milligram times 4 hours in bile. In acute
infectious hepatitis
patients, the mean cumulative radioactivity readings for both plasma and bile in 4 hours were approximately twice that found in control subjects. In mild cirrhotic patients with
enlarged liver
on scintigram, the mean cumulative radioactivity readings for both plasma and bile were approximately 1.4 times that in control subjects. In patients with more advanced cirrhosis and markedly small livers on scintigram, the mean cumulative radioactivity readings for both plasma and bile were as low as approximately 0.5 that of control subjects. These findings seem to indicate the important role of the liver in the production of the nonerythropoietic component of early bilirubin in man.
...
PMID:The effects of acute infectious hepatitis and cirrhosis of the liver on the nonerythropoietic component of early bilirubin. 124 90
Hepatitis A
is an acute, necroinflammatory disease of the liver which results from infection by the
hepatitis A
virus (HAV). The mean incubation period is approximately 30 days. Although the disease is usually self-limited, the severity of illness is age-dependent. In children,
hepatitis A
is usually asymptomatic, while in adults, symptomatic infection is characteristic and jaundice is common. Fulminant hepatitis A is rare and is also age-dependent. The onset of
hepatitis A
is often abrupt and characteristic prodromal symptoms are followed, within a few days to a week, by dark urine and jaundice. Mild to moderate tenderness over an
enlarged liver
is usually detected. Serum alanine and aspartate aminotransferase levels usually both rise rapidly during the prodromal period, reach peak levels and then decrease by approximately 75% per week. Serum bilirubin concentrations reach peak levels later and decline less rapidly than serum aminotransferases. Nonetheless, the period of jaundice persists for < 2 weeks in approximately 85% of cases. Nearly all adult patients with clinically apparent disease experience complete clinical recovery with restoration of normal serum bilirubin and aminotransferase values by 6 months. Relapses and prolonged cholestasis are unusual manifestations of
hepatitis A
, and even in these circumstances, recovery is the rule and chronic hepatitis is not seen. The diagnosis of
hepatitis A
requires the detection of immunoglobulin M antibody to HAV in a patient who presents with, or has recently had, clinical features of hepatitis (icteric or anicteric disease) or in an individual with inapparent, asymptomatic infection in whom serum aminotransferase elevations may be detected.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Clinical manifestations and diagnosis of hepatitis A virus infection. 133 49
Seven cases of Budd-Chiari syndrome are reported in children. The mode of onset was fulminant in one case with rapidly lethal liver failure, acute in 5 cases with rapid appearance of
hepatomegaly
and ascites and insidious in one case, with isolated
hepatomegaly
.
Hepatomegaly
, which is a constant sign, was present in the 7 patients. Ascites and collateral venous circulation were present in 6, splenomegaly in 2 and moderate jaundice in one only. Liver function tests, deeply abnormal in the patient with fulminant liver failure, was only slightly abnormal in the 6 others. Diagnosis was corroborated by ultrasonography, cavography, hepatic veins angiography and liver biopsy in 6 patients and by post mortem examination in the 7th. Etiologic investigations did not allow finding the cause of Budd-Chiari syndrome. However, this series can be distinguished by associated total villous atrophy in 3 cases, psoriasis in one, hepatitis B in one,
hepatitis A
and intestinal giardiasis in one. Portasystemic shunts were performed in 3 patients. One died in the immediate postoperative period, the 2 others are presently in good health with a 5 and 6 1/2 year-follow-up. One patient died rapidly from fulminant liver failure. Another, untreated, died 16 years after the onset of the disease, from an unknown cause. Two patients are lost to follow-up.
...
PMID:[Budd-Chiari syndrome in children. Apropos of 7 cases]. 206 74
In 1964 a 42-year-old woman was hospitalized with clinical and laboratory signs of posttransfusion hepatitis five weeks after administration of six whole blood transfusions. During the following 17 years anicteric chronic liver disease was repeatedly documented by elevations of serum aspartate aminotransferase (SGOT) and alkaline phosphatase enzymes. In 1981
hepatomegaly
, progressive jaundice, and a serum alphafetoprotein level of 516,000 ng/ml were observed. Percutaneous liver biopsy showed a primary hepatocellular carcinoma (PHC). Serologic examinations failed to reveal markers for hepatitis B virus including HBsAg, anti-HBs, and anti-HBc by radioimmunoassay; antibody to
hepatitis A
virus was also absent. This sequence of events demonstrates a presumptive association of PHC and the agent(s) of non-A, non-B viral hepatitis.
...
PMID:Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis. 619 33
A 12 year old boy with Burkitt's lymphoma developed severe hepatitis with
hepatomegaly
, subclinical jaundice, and a small rise in body temperature, associated with an important rise in SGPT and fall in prothrombin titres, 6 days after anticancer chemotherapy and 24 hours after halothane anaesthesia.
Hepatitis A
and B serology remained negative. This hepatic failure explained perhaps the unusually severe vincristine toxicity which gave rise to a polyneuritis with important sequelae. The association of halothane hepatitis with antimitotic drugs appeared particularly dangerous, and halothane should probably be avoided in all patients been given or about to be given anticancer chemotherapy.
...
PMID:[Post-anesthetic hepatitis. The role of halothane and antimitotic combinations]. 674 42
Ground water that was used as a source of potable water by residents of a small community became contaminated by leachate from a 300,000 barrel pesticide waste dump. An environmental health survey of the residents and an apparent control group was conducted to determine if any adverse health effects resulting from exposure to the toxic compounds, many of which were hepatotoxins, could be detected. The survey utilized a health questionnaire, a clinical examination, and a biochemical screening. The latter included analysis of serum for liver and kidney function parameters, determination of
hepatitis A
and B serology, and bile acid determinations on fasting and postprandial serum and urine specimens. Air and water from representative homes and urine from study participants were analyzed for selected organic compounds. The biochemical screening was conducted on two occasions 2 months apart. The initial hepatic profile testing revealed elevated concentrations of the serum enzymes, alkaline phosphatase and serum glutamic oxaloacetic transaminase, in residents who had used the contaminated water. During follow-up testing of these same persons 2 months later, these values were significantly reduced, as were postprandial serum concentrations of the bile acid of cholyglycine. Six individuals in the exposed group had slight
hepatomegaly
compared to one individual in the intermediate exposure group and none in the controls. Concentrations of carbon tetrachloride were as high as 18,700 microgram/L in the well water samples. The biochemical and clinical observations are suggestive of a transitory liver injury probably related to exposure to the contaminated drinking water.
...
PMID:An environmental health survey of drinking water contamination by leachate from a pesticide waste dump in Hardeman County, Tennessee. 705 35
Forty-one Egyptian schoolchildren (36 boys and five girls; age, 12-16 years) who were heavily infected with Schistosoma mansoni were studied. Symptomatic subjects had swimmer's itch and hematochezia.
Hepatomegaly
was found in 39 and splenomegaly in 31 children. All subjects had eosinophilia, 13 had anemia, 31 had elevated levels of serum globulins, and nine had elevated levels of alkaline phosphatase. All but one subject had antibody to
hepatitis A
virus, and 26 had antibody to hepatitis B core antigen, antibody to hepatitis B surface antigen, or both. Oxamniquine was given in single daily doses of 20 mg/kg of body weight for either two or three days and cured 50% and 85%, respectively, of subjects treated; ova excretion was reduced by 86%-93% for up to 12 months. Morbidity was associated with heavy S. mansoni infection. Therapy with oxamniquine was safe and efficacious.
...
PMID:Clinical characteristics and response to therapy in Egyptian children heavily infected with Schistosoma mansoni. 708 3
A study of the clinical profile of 59 patients who presented with
hepatitis A
virus infection showed that dark urine, fatigue, gastrointestinal complaints, and fever were the most common presenting symptoms. The most frequent physical findings were
hepatomegaly
and jaundice. The mean presenting laboratory tests included total bilirubin of 5 mg/dL, alkaline phosphatase of 269 units/L, and serum aspartate aminotransferase and alanine aminotransferase levels of 1442 mIU/mL and 1952 mIU/mL, respectively. Atypical manifestations included relapse, cholestasis, rash, and arthralgia. Two patients presented with
hepatitis A
and concomitant type I autoimmune chronic hepatitis, and both required immunosuppressive therapy. Five patients who presented with
hepatitis A
were pregnant, and during follow-up, none of their infants developed elevated serum transaminase values or had detectable IgM anti-HAV antibody. All 59 patients experienced complete clinical and biochemical recovery within 6 months after onset of illness.
...
PMID:Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. 787 41
1
2
3
Next >>